MetLife Investment Management’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
13,482
-608
-4% -$44.7K 0.01% 1385
2025
Q4
$957K Sell
14,090
-1,289
-8% -$80.5K ﹤0.01% 1451
2025
Q3
$877K Hold
15,379
﹤0.01% 1525
2025
Q2
$852K Hold
15,379
0.01% 1390
2025
Q1
$672K Sell
15,379
-250
-2% -$10.9K ﹤0.01% 1557
2024
Q4
$673K Buy
15,629
+856
+6% +$38.6K ﹤0.01% 1632
2024
Q3
$660K Buy
14,773
+8,324
+129% +$344K ﹤0.01% 1628
2024
Q2
$248K Buy
+6,449
New +$246K ﹤0.01% 2115

Other funds holding DBD

MetLife Investment Management's DBD Position: Q1 2026 in Review

MetLife Investment Management reduced its Diebold Nixdorf (DBD) stake by 4.3% in Q1 2026, selling an estimated $44.7K and leaving 13,482 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #1385.

MetLife Investment Management first reported a position in DBD in Q2 2024 and has held it in 8 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • MetLife Investment Management held 13,482 shares of Diebold Nixdorf worth $1.02M as of Q1 2026.
  • MetLife Investment Management sold 608 Diebold Nixdorf shares in Q1 2026, an estimated $44.7K.
  • Diebold Nixdorf made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1385 holding.
  • MetLife Investment Management first reported a position in Diebold Nixdorf in Q2 2024 and has held it in 8 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.